Am Heart J

1. HOLMEN S, Manintveld O, Damman K, Braun O, et al
   DAPAgliflozin for Renal protection in Heart Transplant recipients. Rationale and design of the randomized controlled DAPARHT trial.
   Am Heart J. 2025 Aug 19:S0002-8703(25)00300-X. doi: 10.1016/j.ahj.2025.
   

   >> Share

   
   

   
   Can J Cardiol

2. YOUNIS A, ElZalabany S, Miranda WR, Connolly HM, et al
   Outcomes After Heart Transplantation in Adults with Congenital Heart Disease - A Single Center Experience.
   Can J Cardiol. 2025 Aug 22:S0828-282X(25)01020.
   

   >> Share

   
   

   
   Circ Heart Fail

3. LANG FM, Liu J, Clerkin KJ, Driggin EA, et al
   Sarcopenia Assessment Using Fully Automated Deep Learning Predicts Cardiac Allograft Survival in Heart Transplant Recipients.
   Circ Heart Fail. 2025 Aug 20:e012805. doi: 10.1161/CIRCHEARTFAILURE.125.012805.
   

   >> Share

   
   
4. FOX DK, Waken RJ, Wang F, Avula K, et al
   Changes in Heart Transplant Listings by Insurance and Race During the COVID Public Health Emergency.
   Circ Heart Fail. 2025 Aug 20:e012306. doi: 10.1161/CIRCHEARTFAILURE.124.012306.
   

   >> Share

   
   

   
   Clin Transplant

5. ENDO T, Chandrashekhar P, Gallo M, Schumer EM, et al
   UNOS 2018 Heart Allocation Policy: Evaluation of Status 1 and 2 Extensions on Heart Transplant Outcomes.
   Clin Transplant. 2025;39:e70283.
   

   >> Share

   
   
6. NASHER N, Rahimov D, Macmillan TR, Siddique F, et al
   Heart Allograft Utilization Rates Following Donation After Circulatory Death Compared to Donation After Brain Death in the Ideal Heart Donor.
   Clin Transplant. 2025;39:e70266.
   

   >> Share

   
   
7. WEN Z, Shao S, Feng Y, Wang Z, et al
   Altered Immune Profiles in Non-Failing Heart Donors With Induced Long QT Syndrome: A Potential Risk Factor for Cardiac Allograft Vasculopathy.
   Clin Transplant. 2025;39:e70286.
   

   >> Share

   
   
8. HUANG X, Chen L, Liu L, Zhou Y, et al
   Five-Aminolevulinic Acid as a Potential Biomarker for Renal Insufficiency After Heart Transplantation.
   Clin Transplant. 2025;39:e70284.
   

   >> Share

   
   
9. HENRY B, Garraffo A, Consigny PH, Rouzaud C, et al
   Travel Practices and Associated Risks in Adult Thoracic Transplant Recipients: A Monocentric Survey.
   Clin Transplant. 2025;39:e70206.
   

   >> Share

   
   

   
   J Heart Lung Transplant

10. KIM DY, Kang M, Kim J, Choi D, et al
    Machine perfusion across different donor pathways in heart transplantation: A systematic review and network meta-analysis.
    J Heart Lung Transplant. 2025 Aug 22:S1053-2498(25)02214.
    

    >> Share

    
    
11. HOLLIS P, Issitt R, Lava SAG, Laurence C, et al
    ABO-incompatible heart transplants in children aged 2-9 years: a new paradigm in transplant?
    J Heart Lung Transplant. 2025 Aug 20:S1053-2498(25)02197.
    

    >> Share

    
    
12. CHO PD, Zappacosta H, Song J, White JP, et al
    Predictors and Outcomes for Severe Primary Graft Dysfunction in Heart Transplantation: United States Cohort Analysis.
    J Heart Lung Transplant. 2025 Aug 20:S1053-2498(25)02202.
    

    >> Share

    
    
13. KARIM SR, Jensen NM, Holck EN, Clemmesen TS, et al
    Impact of Evolocumab on Coronary Physiology and Microstructure in De-Novo Heart Transplant Recipients.
    J Heart Lung Transplant. 2025 Aug 20:S1053-2498(25)02203.
    

    >> Share

    
    
14. KILLIAN AC, Venkateswaran R
    Donation after circulatory death heart transplantation in the United States continues to steadily increase but maintains unrealized potential to address the organ shortage.
    J Heart Lung Transplant. 2025 Aug 19:S1053-2498(25)02205.
    

    >> Share

    
    

    
    J Thorac Cardiovasc Surg

15. BENKERT AR, Jawitz OK, Lobo AA, Casalinova S, et al
    Five-Year Experience of Heart Transplantation Following Donation After Circulatory Death.
    J Thorac Cardiovasc Surg. 2025 Aug 19:S0022-5223(25)00667.
    

    >> Share

    
    

    
    Transplant Proc

16. VAZ TCD, Paredes CE, Aiello VD, Arrieta SR, et al
    Case Report: Chylopericardium after Heart Transplantation due to Lymphatic Malformation in a Patient With Noonan Syndrome.
    Transplant Proc. 2025 Aug 20:S0041-1345(25)00378.
    

    >> Share

    
    
17. LANZA PG, Azeka PDE
    Nutritional Progression of a Child With Hypoplastic Left Heart Syndrome During the Waiting Period for Heart Transplantation: A Case Report.
    Transplant Proc. 2025 Aug 14:S0041-1345(25)00359.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share